A Case of Concomitant Lung Adenocarcinoma and Pleural Metastasis of Papillary Thyroid Carcinoma With <scp>BRAF V600E</scp> Mutation

A 62-year-old woman with a history of papillary thyroid carcinoma presented to our hospital with fever and cough and was diagnosed with stage IV non-small cell lung carcinoma (NSCLC). One year after chemoimmunotherapy, a re-biopsy of the left pleural tumour lesion was performed. Histological analysis revealed papillary thyroid carcinoma. Another biopsy was performed on the primary tumour, and the histological analysis of the primary tumour lesion confirmed NSCLC. BRAF V600E mutations were detected in both left pleural metastatic lesions of papillary thyroid carcinoma and the primary tumour of NSCLC. Dabrafenib and trametinib reduced both tumour lesions. Here, we report a rare case of concomitant BRAF V600E-mutated NSCLC and pleural metastasis from papillary thyroid carcinoma.

Authors

Institutions

Publication Details

Journal
Respirology Case Reports
Published
2025-02-01
DOI
https://doi.org/10.1002/rcr2.70119
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case of Concomitant Lung Adenocarcinoma and Pleural Metastasis of Papillary Thyroid Carcinoma With BRAF V600E Mutation

Keisuke Nishikawa, Tetsuo Tani, A. Atsumi, Kota Ishioka et al.
Respirology Case Reports
Thyroid Cancer Diagnosis and Treatment
article

A Case of Concomitant Lung Adenocarcinoma and Pleural Metastasis of Papillary Thyroid Carcinoma With BRAF V600E Mutation

Keisuke Nishikawa, Tetsuo Tani, A. Atsumi, Kota Ishioka, Saeko Takahashi, Yasuhide Okamoto
article en

Abstract

A 62-year-old woman with a history of papillary thyroid carcinoma presented to our hospital with fever and cough and was diagnosed with stage IV non-small cell lung carcinoma (NSCLC). One year after chemoimmunotherapy, a re-biopsy of the left pleural tumour lesion was performed. Histological analysis revealed papillary thyroid carcinoma. Another biopsy was performed on the primary tumour, and the histological analysis of the primary tumour lesion confirmed NSCLC. BRAF V600E mutations were detected in both left pleural metastatic lesions of papillary thyroid carcinoma and the primary tumour of NSCLC. Dabrafenib and trametinib reduced both tumour lesions. Here, we report a rare case of concomitant BRAF V600E-mutated NSCLC and pleural metastasis from papillary thyroid carcinoma.

Respirology Case ReportsVol. 13(2)
Saiseikai Central Hospital (JP)
Good health and well-being
Openalex Percentile: Top 96%
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Case of Concomitant Lung Adenocarcinoma and Pleural Metastasis of Papillary Thyroid Carcinoma With <scp>BRAF V600E</scp> Mutation — Keisuke Nishikawa, Tetsuo Tani, et al. · Respirology Case Reports (2025) | TGRS Research Map | TGRS